Delgado Convenes Meeting of Health Care Advisory Committee
ELLENVILLE, NY — Today, Rep. Antonio Delgado hosted a meeting with members of his Health Care Advisory Committee at the Ellenville Regional Hospital to discuss health care needs within the district, ways to address skyrocketing health care costs, and priorities for 2020.
"Today I joined my Health Care Advisory Committee, made up of local health care advocates, patients, hospital administrators, and medical professionals, to hear about the issues folks face when it comes to their health care and discuss ways to address rising health care costs and accessibility, especially in our rural areas," said Rep. Delgado. "Making sure upstate New Yorkers have access to affordable, quality coverage is a top priority for me in Congress. That’s why I have supported legislation to lower the cost of prescription drugs and introduced the Medicare-X Choice Act, which would finally get us to universal coverage by allowing all Americans to purchase a public health insurance plan through the popular Medicare program. I am grateful to everyone who showed up and shared their stories and ideas today.”
This is the fourth in-district advisory committee formed by Rep. Delgado. He has also formed local advisory committees on issues related to veterans, small businesses, and agriculture.
Rep. Delgado has led the House introduction of the Medicare-X Choice Act, public option legislation that would combine Medicare physician networks and reimbursement rates with Affordable Care Act coverage standards to create a new, public health insurance option available to all Americans. Delgado has also joined his colleagues in voting to pass two bipartisan bills to reduce the price of prescription drugs by removing barriers to generic versions of brand-name drugs coming to market, H.R 1503 and H.R. 1520. In December, the House passed Delgado’s Enhancing Retirement Security for Medicare Beneficiaries Act of 2019 as part of H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act. H.R. 3 would generate an estimated $500 billion over the next 10 years by allowing Medicare to negotiate prescription drug costs directly with drug manufacturers and by extending those negotiated rates to the commercial insurance market. Additionally, it would cap annual out-of-pocket drug costs for seniors on Medicare at $2,000 and would reinvest the bill’s savings in life-saving medical research. Delgado’s provision would exclude covered retirement accounts from counting as income for the purposes of determining eligibility under the Medicare Part D low-income subsidy (LIS) program.